-
1 Comment
CAI International, Inc is currently in a long term uptrend where the price is trading 44.7% above its 200 day moving average.
From a valuation standpoint, the stock is 94.7% cheaper than other stocks from the Industrials sector with a price to sales ratio of 2.8.
CAI International, Inc's total revenue sank by 35.8% to $64M since the same quarter in the previous year.
Its net income has increased by 81.5% to $14M since the same quarter in the previous year.
Finally, its free cash flow fell by 1970.6% to $-91M since the same quarter in the previous year.
Based on the above factors, CAI International, Inc gets an overall score of 3/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US1421521071 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 8B |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | nan |
| Dividend Yield | None |
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CAI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
